Trafalgar International (GCAN) Assets Average (2018 - 2026)
Trafalgar International (GCAN) posted Assets Average of $1127.0 for Q1 2026, down 89.83% on a QoQ basis from $11085.0 in Q4 2025, and down 97.83% year-over-year from $51999.0 in Q1 2025.
Analysis
Trafalgar International (GCAN) Assets Average (2018 - 2026) Analysis & Trends
Trafalgar International has reported Assets Average for 9 years, with the latest figure at $1127.0 in Q1 2026.
- On a quarterly basis, Assets Average fell 97.83% year-over-year to $1127.0 in Q1 2026; TTM through Mar 2026 was $1127.0, a 97.83% decrease from a year earlier, with the FY2025 full-year figure at $29300.0, down 74.53% from the prior year.
- Assets Average was $1127.0 for Q1 2026 at Trafalgar International, down from $11085.0 in the prior quarter.
- The five-year high for Assets Average was $387346.5 in Q1 2022, with the low at $1127.0 in Q1 2026.
- Average Assets Average over 5 years is $165039.8, with a median of $152883.0 recorded in 2024.
- The sharpest annual moves came in 2022 and 2026: Assets Average soared 40.15% in 2022, then plunged 97.83% in 2026.
- Over 5 years, Assets Average stood at $290604.0 in 2022, then plunged by 34.88% to $189237.5 in 2023, then slumped by 67.84% to $60867.0 in 2024, then plunged by 81.79% to $11085.0 in 2025, then plunged by 89.83% to $1127.0 in 2026.
- The last three Assets Average figures came in at $1127.0 (Q1 2026), $11085.0 (Q4 2025), and $24033.5 (Q3 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 643.26 Bn | 622.50 Bn | 17.26 Bn | 200.98 Bn |
| 2 | AbbVie | 443.31 Bn | 436.74 Bn | 12.70 Bn | 135.79 Bn |
| 3 | Merck | 364.74 Bn | 357.60 Bn | 12.21 Bn | 129.24 Bn |
| 4 | Novartis Ag | 266.46 Bn | 258.77 Bn | 11.24 Bn | 120.28 Bn |
| 5 | Pfizer | 158.57 Bn | 146.88 Bn | 10.94 Bn | 204.57 Bn |
| 6 | Sanofi | 52.33 Bn | 44.95 Bn | 10.79 Bn | 149.95 Bn |
| 7 | Revolution Medicines | 43.79 Bn | 43.79 Bn | - | 3.29 Bn |
| 8 | Incyte | 25.23 Bn | 20.69 Bn | 1.57 Bn | 7.61 Bn |
| 9 | United Therapeutics | 21.67 Bn | 19.01 Bn | 683.80 Mn | 6.97 Bn |
| 10 | Trafalgar International | 217,335.05 | 217,335.05 | - | 1,127.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2026 | 1,127.00 |
| Dec 31, 2025 | 11,085.00 |
| Sep 30, 2025 | 24,033.50 |
| Jun 30, 2025 | 36,462.50 |
| Mar 31, 2025 | 51,999.00 |
| Dec 31, 2024 | 60,867.00 |
| Sep 30, 2024 | 73,591.00 |
| Jun 30, 2024 | 108,361.50 |
| Mar 31, 2024 | 152,883.00 |
| Dec 31, 2023 | 189,237.50 |
| Sep 30, 2023 | 227,431.50 |
| Jun 30, 2023 | 254,692.00 |
| Mar 31, 2023 | 270,583.50 |
| Dec 31, 2022 | 290,604.00 |
| Sep 30, 2022 | 312,437.50 |
| Jun 30, 2022 | 352,935.00 |
| Mar 31, 2022 | 387,346.50 |
| Dec 31, 2021 | 451,356.00 |
| Sep 30, 2021 | 546,686.00 |
| Jun 30, 2021 | 478,118.00 |